Used as a synthetic intermediate in pharmaceutical research, particularly in the development of central nervous system agents. Its structure supports the design of compounds targeting neurological disorders due to the presence of a constrained pyrrolidine ring and ester functionality. Commonly employed in medicinal chemistry for structure-activity relationship studies, especially in optimizing bioavailability and receptor selectivity. Also utilized in the preparation of analogs for cognitive enhancers and psychiatric medications.